期刊文献+

降钙素原变化率在评估脓毒症患者预后中的价值 被引量:10

Prognostic evaluation of procalcitonin clearance for sepsis
下载PDF
导出
摘要 目的:探讨静脉血中降钙素原(Procalcitonin,PCT)及其变化率在评估脓毒症患者预后中的价值。方法对急诊重症监护室收治的72例脓毒症患者,分别于入室即刻(PCT1)、入室后72 h(PCT2)检测静脉血中PCT含量,并计算PCT变化率。患者入室后24 h内利用急性生理学和慢性健康状况评价Ⅱ(APACHEⅡ)进行评分。以患者入室后28 d生存状况,将患者分为存活组(52例)和死亡组(20例),比较两组患者不同时点静脉血中PCT含量、PCT变化率及APACHEⅡ评分对预测患者预后的价值。结果存活组和死亡组患者入室即刻PCT含量分别为14.72μg·L^-1(7.82~20.25μg·L^-1)比18.25μg·L^-1(13.43~21.83μg·L^-1),两组差别有统计学意义(P=0.047);存活组和死亡组患者72 h PCT含量分别为4.11μg·L^-1(2.03~8.22μg·L^-1)比12.33μg·L-1(8.21~15.76μg·L^-1),两组差别有统计学意义(P=0.000);存活组和死亡组患者PCT变化率依次为0.718(0.589~0.827)比0.365(0.256~0.57),两组差别有统计学意义(P=0.000)。PCT变化率预测患者预后价值同APACHEⅡ评分一致,但优于不同时点静脉血中PCT含量,其ROC曲线下面积(AUC)为0.814,敏感度82.7%,特异度75%。结论患者静脉血中PCT变化率可作为判断脓毒症患者预后的指标之一,其预测能力优于入室即刻PCT和72 h PCT含量的预测能力。 Objective To investigate the prognostic value of procalcitonin (PCT)and PCT clearance in patients with sepsis in emer-gency intensive care unit (EICU).Methods 72 cases with sepsis were included in the present study.PCT was measured at admis-sion,72 hours after admission and the PCT clearance was also calculated.Meanwhile,Acute Physiology and Chronic Health Evaluation II (APACHE II)score was recorded within 24 hours.Patients were divided into two groups (survivors and non-survivors)according to 28d mortality.The PCT of two different points,PCT clearance,and APACHE II scores were compared between the survivors and non-survivors Results Significant difference of PCT at admission,72 hours after admission and the PCT clearance were found between the survivors and non-survivors groups with 14.72 μg·L-1 (7.82 ~20.25 μg·L-1 )vs 18.25 μg·L-1 (13.43 ~21.83 μg·L-1 ) (P =0.047),4.11 μg·L-1 (2.03 ~8.22 μg·L-1 )vs 12.33 μg·L-1 (8.21 ~15.76 μg·L-1 )(P =0.000),and 0.718 (0.589~0.827)vs 0.365 (0.256~0.57)(P =0.000),respectively.Prognostic value of the PCT clearance is consistent with A-PACHEⅡ score,but better than the PCT content of the venous blood at different time points.The area under the ROC was 0.849 with sensitivity 78%,specificity 89.2%.Conclusions PCT clearance maybe can be used as a prognostic indicator,which was better than using PCT at admission and 72h after admission.
出处 《安徽医药》 CAS 2015年第5期875-878,共4页 Anhui Medical and Pharmaceutical Journal
基金 安徽省自然科学基金(No 1208085MH150)
关键词 降钙素原 降钙素原变化率 脓毒症 急诊重症监护室 procalcitonin procalcitonin clearance sepsis emergency intensive care unit
  • 相关文献

参考文献15

  • 1韩文龙,唐晓林.高乳酸血症时间对重症脓毒症患者预后的评估价值[J].安徽医药,2014,18(7):1329-1330. 被引量:2
  • 2Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis [ J ]. Virulence ,2014,5 ( 1 ) :4 - 11.
  • 3Lopez-Bushnell K, Demaray WS ,Jaeo C. Reducing sepsis mortality [J]. Medsurg Nuts,2014,23( 1 ) :9 -14.
  • 4Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Cam- paign : international guidelines for management of severe sepsis and septic shock,2012 [ J ]. Intensive Care Med, 2013,39 ( 2 ) : 165 - 228.
  • 5崔晓莉,王忠勇,赵宏胜,张彬,王林华,陆洋.降钙素原对重症患者细菌感染预后的预测价值[J].中华急诊医学杂志,2013,22(6):630-633. 被引量:55
  • 6Nargis W, Ibrahim M, Ahamed BU. Procalcitonin versus C-reactive protein:Usefulness asbiomarker of sepsis in ICU patient [ J ]. Int J Crit Illn Inj Sci,2014,4(3) :195 -199.
  • 7Tasdelen Fisgin N, Aliyazicioglu Y, Tanyel E, et al. The value of neopterin and procaleitonin in patients with sepsis [ J ]. South Med J,2010,103 (3) :216 -219.
  • 8Levy MM,Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/AC- CP/ATS/SIS International Sepsis Definitions Conferenee [ J ]. Crit Care Med ,2003,31 (4) : 1250 - 1256.
  • 9An G, Namas RA, Vodovotz Y. Sepsis : from pattern to mechanism and back [ J ]. Crit Rev Biomed Eng,2012,40 (4) :341 -351.
  • 10Zhou J, Qian C, Zhao M, et al. Epidemiology and outcome of severe sepsis and septic shock in intensive eare units in China's Mainland [J]. PLoS 0ne,2014,9(9) :1 -8.

二级参考文献59

  • 1葛庆岗,阴赪宏,文艳,吕旌乔,王谊冰.血清降钙素原与多器官功能障碍综合征严重程度相关性的临床研究[J].中国危重病急救医学,2005,17(12):729-731. 被引量:28
  • 2成人严重感染与感染性休克血流动力学监测与支持指南[J].中华急诊医学杂志,2007,16(2):121-126. 被引量:68
  • 3费军,余洪俊,梁华平,黄显凯,蒋耀光.严重多发伤患者血清降钙素原水平变化与脏器功能不全的相关性[J].中华急诊医学杂志,2007,16(6):572-575. 被引量:10
  • 4Castelli GP, Pognani C, Cita M, et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol, 2006, 72 : 69-80.
  • 5Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992,101 : 1644-1655.
  • 6Kushimoto S, Shibata Y, Koido Y, et al. The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy. J Nihon Med Sch, 2007, 74:236-240.
  • 7Lee CC, Chen SY, Tsai CL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock, 2008, 29 : 322-327.
  • 8Dandona P,Nix D,Wilson MF,et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab, 1994,79:1605-1608.
  • 9Castelli GP, Pognani C, Cita M, et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis [J]. Minerva Anestesiol, 2006, 72 (1/2): 69 -80.
  • 10Kushimoto S, Shibata Y, Koido Y, et al. The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy [J]. Nihon Med Sch, 2007, 74 (3) : 236-240.

共引文献215

同被引文献87

  • 1YoussefD,Abd-ElrahmanH,ShehabMM,etal.Incidenceofacutekidneyinjuryintheneonatalintensivecareunit[J].SaudiJKid-neyDisTranspl,2015,26(1):67-72.
  • 2TagamiT,MatsuiH,FushimiK,etal.Useofrecombinanthumansolublethrombomodulininpatientswithsepsis-induceddissemina-tedintravascularcoagulationafterintestinalperforation[J].FrontMed(Lausanne),2015,2:7.
  • 3WadaH,MatsumotoT,AotaT,etal.Progressindiagnosisandtreatmentfordisseminatedintravascularcoagulation[J].RinshoKetsueki,2015,56(2):169-176.
  • 4ZhaoT,LiY,LiuB,etal.Histonedeacetylaseinhibitortreatmentattenuatescoagulationimbalanceinalethalmurinemodelofsepsis[J].Surgery,2014,156(2):214-220.
  • 5KilicY,TopcuI,BambalH,etal.Thromboelastographyinthee-valuationofcoagulationdisordersinpatientswithsepsis[J].TurkJMedSci,2014,44(2):267-272.
  • 6MatsumotoS,SudaK,IimotoS,etal.Prospectivestudyofdeepveinthrombosisinpatientswithspinalcordinjurynotreceivingan-ticoagulanttherapy[J].SpinalCord,2015,53(4):306-309.
  • 7TassinM,LlarenaP,LaffayeF,etal.ProteinCdeficiencyinpa-tientwithsepsis-associateddisseminatedintravascularcoagulationanddeepveinthrombosis[J].ArchArgentPediatr,2013,111(1):e28-e30.
  • 8ShawAD,VailGM,HaneyDJ,etal.SevereproteinCdeficiencyisassociatedwithorgandysfunctioninpatientswithseveresepsis[J].JCritCare,2011,26(6):539-545.
  • 9Vincent JL. Clinical sepsis and septic shock - definition, diagnosis and management principles [ J ]. Langenbeck Arch Surg,2008,393 (6) :817 -824.
  • 10Hoyen DL, Arias E, Smith BL, et al. Deaths : final data for 2008 [ J ]. Natl vital statistics Reports,2009,49 ( 8 ) : 110 - 113.

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部